90,279 Shares Sold in 10b5-1; AIP (NASDAQ: AIP) Form 144

Rhea-AI Filing Summary

AIP reported sale notices and related 10b5-1 transactions. The filing lists an issuer notice to sell 90,000 common shares from previously exercised stock options dated 12/28/2020, and discloses 10b5-1 sales of common shares on 02/25/2026, 02/26/2026, and 02/27/2026.

The excerpt shows executed 10b5-1 trades of 4,907, 73,610, and 11,762 common shares (totaling 90,279 shares) with reported proceeds in dollars. Shares outstanding are listed as 45,467,261 as of 03/02/2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	90000	1529100.00	45467261	03/02/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/28/2020	Previously Exercised Stock Options	Issuer			90000	12/28/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	02/27/2026	11762	200046.65
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	02/26/2026	73610	1261795.28
10b5-1 Sales for S A RAZA & N SARAIYA CO-TTEES ATIQ RAZA & N SARAIYA 2012 REV TRU/A DTD 11/26/2012 900 E. Hamilton Ave., Suite 300 Campbell CA 95008	Common	02/25/2026	4907	83419.50

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does AIP's Form 144 disclose about planned sales?

It discloses an issuer notice to sell 90,000 common shares. The filing lists those shares as from previously exercised stock options dated 12/28/2020 and identifies cash as the consideration method for that sale.

How many shares were sold under 10b5-1 plans for AIP in late February 2026?

10b5-1 trades reported total 90,279 shares. The filing shows sales of 4,907 shares on 02/25/2026, 73,610 shares on 02/26/2026, and 11,762 shares on 02/27/2026, with dollar proceeds listed per trade.

What proceeds were reported for the largest 10b5-1 trade in the filing?

The 73,610-share sale reported proceeds of $1,261,795.28. That trade is listed for 02/26/2026 and appears as part of the 10b5-1 activity disclosed in the excerpt.

What is AIP's shares outstanding figure shown in the filing?

Shares outstanding are 45,467,261 as of 03/02/2026. That figure appears on the excerpt’s securities header and provides a context for the reported sales activity.